Bill & Melinda Gates Foundation
Country
Estados Unidos
Sponsor name
Bill & Melinda Gates Foundation
Research Outputs
(All)
Results 1-6 of 6 (Search time: 0.003 seconds).
Experimental human challenge defines distinct pneumococcal kinetic profiles and mucosal responses between colonized and non-colonized adults [2021-01]
Nikolaou, Elissavet; Jochems, Simon P.; Mitsi, Elena; Pojar, Sherin; Blizard, Annie; Reiné, Jesus; Solórzano, Carla; Negera, Edessa; Carniel, Beatriz; Schanoski, Alessandra Soares
mBio v. 14, n. 1, e02020-20, jan. 2021
Innate and adaptive nasal mucosal immune responses following experimental human pneumococcal colonization [2019]
Jochems, Simon P.; Ruiter, Karin de; Solórzano, Carla; Voskamp, Astrid; Mitsi, Elena; Nikolaou, Elissavet; Carniel, Beatriz F.; Pojar, Sherin; German, Esther L.; Reiné, Jesús; Schanoski, Alessandra Soares
J. clin. invest. v. 129, n. 10, p. 4523-4538, jul. 2019
Landscape analysis of pharmacovigilance and related practices among 34 vaccine manufacturers’ from emerging countries [2020]
Hartmann, Katharina; Pagliusi, Sonia; Precioso, Alexander Roberto
Vaccine v. 38, n. 34, p. 5490-5497, jul. 2020
Streptococcus pneumoniae nasopharyngeal colonizationmicroaspirationalveolar macrophagesinterferon-gamaCD4+ T cells
Nasal pneumococcal density is associated with microaspiration and heightened human alveolar macrophage responsiveness to bacterial pathogens [2019]
Mitsi, Elena; Carniel, Beatriz; Reiné, Jesús; Rylance, Jamie; Zaidi, Seher; Schanoski, Alessandra Soares
Am. J. Respir. Crit. Care Med. v. 201, n. 3, out. 2019
Serum levels of anti-PspA and anti-PspC IgG decrease with age and do not correlate with susceptibility to experimental human pneumococcal colonization [2021-02]
Adriano Palharini de Araujo



PloS One v. 16, n. 2, e0246540, fev. 2021
When could human challenge trials be deployed to combat emerging infectious diseases? Lessons from the case of a Zika virus human challenge trial [2019]
Palacios, Ricardo
Trials v. 20, suppl. 2, 702, dez. 2019